OPEN IN READ APP
JOURNAL ARTICLE

Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort

Mónica Fernández, Graciela S Alarcón, Gerald McGwin, Martha L Sanchez, Mandar Apte, Luis M Vilá, John D Reveille et al.
Arthritis and Rheumatism 2007 August 15, 57 (6): 986-92
17665468

OBJECTIVE: To determine if overall health status as assessed by the Short Form 6D (SF-6D) index, a preference-based generic measure of health, is associated with the occurrence of damage accrual and mortality in patients with systemic lupus erythematosus (SLE).

METHODS: We studied SLE patients (American College of Rheumatology criteria) from the LUpus in MInorities, NAture versus nurture cohort (LUMINA), a longitudinal multiethnic cohort. The contribution of the SF-6D as assessed at enrollment to damage accrual at the last visit and mortality was examined. All variables previously shown to be determinants of damage accrual and mortality and corroborated by univariable analyses were adjusted for in multivariable models (Poisson and Cox proportional hazards regressions, respectively). Damage accrual and mortality were the dependent variables. Similar analyses were performed examining the associations of the Short Form 36 summary measures (physical component summary [PCS], mental component summary [MCS]) with these outcomes.

RESULTS: In 552 patients, the SF-6D was negatively associated with damage accrual and mortality in the univariable analyses; the association with damage was confirmed in the multivariable analyses (chi(2) = 9.020, P = 0.002) but the association with mortality was not confirmed (hazard ratio 0.495, 95% confidence interval 0.041-6.038). When the PCS and MCS were evaluated, the PCS, but not the MCS, was found to be associated with damage but not with mortality.

CONCLUSION: The SF-6D (and the PCS) as measured early in the disease course were found to independently predict damage accrual at the last visit, but not mortality. Although the SF-6D was originally conceived as a utility measure, it may be used to accurately assess overall health status in patients with SLE.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read
17665468
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"